AU2001257230B2 - Ultrashort acting hypnotic barbiturates - Google Patents
Ultrashort acting hypnotic barbiturates Download PDFInfo
- Publication number
- AU2001257230B2 AU2001257230B2 AU2001257230A AU2001257230A AU2001257230B2 AU 2001257230 B2 AU2001257230 B2 AU 2001257230B2 AU 2001257230 A AU2001257230 A AU 2001257230A AU 2001257230 A AU2001257230 A AU 2001257230A AU 2001257230 B2 AU2001257230 B2 AU 2001257230B2
- Authority
- AU
- Australia
- Prior art keywords
- alkyl
- unbranched
- branched
- unsaturated
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
- C07D239/62—Barbituric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
- C07D239/66—Thiobarbituric acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19914400P | 2000-04-24 | 2000-04-24 | |
| US60/199,144 | 2000-04-24 | ||
| PCT/US2001/013246 WO2001081319A2 (en) | 2000-04-24 | 2001-04-24 | Ultrashort acting hypnotic barbiturates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2001257230A1 AU2001257230A1 (en) | 2002-01-24 |
| AU2001257230B2 true AU2001257230B2 (en) | 2006-09-14 |
Family
ID=22736404
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001257230A Ceased AU2001257230B2 (en) | 2000-04-24 | 2001-04-24 | Ultrashort acting hypnotic barbiturates |
| AU5723001A Pending AU5723001A (en) | 2000-04-24 | 2001-04-24 | Ultrashort acting hypnotic barbiturates |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU5723001A Pending AU5723001A (en) | 2000-04-24 | 2001-04-24 | Ultrashort acting hypnotic barbiturates |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US6387914B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1276728A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2003531196A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2001257230B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2404898A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2001081319A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1276728A2 (en) * | 2000-04-24 | 2003-01-22 | ARYx Therapeutics | Ultrashort acting hypnotic barbiturates |
| US6750238B1 (en) * | 2000-05-12 | 2004-06-15 | The University Of Toledo | Aralkyl ester soft drugs |
| US6756047B2 (en) * | 2000-05-12 | 2004-06-29 | The University Of Toledo | Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| US7049326B2 (en) * | 2000-05-12 | 2006-05-23 | The University Of Toledo | Method and compositions for temporarily incapacitating subjects |
| US10537061B2 (en) * | 2010-02-26 | 2020-01-21 | Cnh Industrial America Llc | System and method for controlling harvest operations |
| US20150190410A1 (en) * | 2012-07-16 | 2015-07-09 | Dignity Health | Use of creatine and phosphocreatine in the treatment of epilepsy and alcohol addiction |
| US10117891B2 (en) | 2014-09-16 | 2018-11-06 | India Globalization Capital, Inc. | Cannabinoid composition for treating pain |
| US10751300B2 (en) | 2015-01-25 | 2020-08-25 | India Globalization Capital, Inc. | Composition and method for treating seizure disorders |
| US10596159B2 (en) | 2015-08-12 | 2020-03-24 | India Globalization Capital, Inc. | Method and composition for treating cachexia and eating disorders |
| EP3471746A4 (en) | 2016-06-15 | 2020-02-26 | India Globalization Capital, Inc. | METHOD AND COMPOSITION FOR TREATING CRAMPING SEASONS |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2405732A1 (de) * | 1974-02-07 | 1975-08-21 | Bayer Ag | Ekto- und endoparasitenmittel |
| US4237270A (en) * | 1975-02-17 | 1980-12-02 | Spofa, United Pharmaceutical Works | Derivatives of carboxyalkyl imino- and thioxo-barbituric acids |
| US4634707A (en) * | 1983-12-19 | 1987-01-06 | Uniroyal Chemical Company | 5-Pyrimidinecarboxamides and treatment of leukemia and tumors therewith |
| WO1991008191A1 (en) * | 1989-11-14 | 1991-06-13 | Sloan-Kettering Institute For Cancer Research | Novel potent inducers of terminal differentiation and method of use thereof |
| WO1993020064A1 (en) * | 1992-04-06 | 1993-10-14 | Biosite Diagnostics Incorporated | Novel barbiturate derivatives and protein and polypeptide barbiturate derivative conjugates and labels |
| WO1998058925A1 (en) * | 1997-06-21 | 1998-12-30 | Roche Diagnostics Gmbh | Barbituric acid derivatives with antimetastatic and antitumor activity |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH678394A5 (cg-RX-API-DMAC7.html) * | 1990-08-22 | 1991-09-13 | Cerny Erich H | |
| JPH06214344A (ja) * | 1992-10-22 | 1994-08-05 | Konica Corp | ハロゲン化銀写真感光材料 |
| JPH07120865A (ja) * | 1993-10-21 | 1995-05-12 | Konica Corp | ハロゲン化銀写真感光材料 |
| EP1276728A2 (en) * | 2000-04-24 | 2003-01-22 | ARYx Therapeutics | Ultrashort acting hypnotic barbiturates |
-
2001
- 2001-04-24 EP EP01930722A patent/EP1276728A2/en not_active Withdrawn
- 2001-04-24 US US09/841,738 patent/US6387914B2/en not_active Expired - Fee Related
- 2001-04-24 JP JP2001578413A patent/JP2003531196A/ja active Pending
- 2001-04-24 CA CA002404898A patent/CA2404898A1/en not_active Abandoned
- 2001-04-24 AU AU2001257230A patent/AU2001257230B2/en not_active Ceased
- 2001-04-24 AU AU5723001A patent/AU5723001A/xx active Pending
- 2001-04-24 WO PCT/US2001/013246 patent/WO2001081319A2/en not_active Ceased
-
2002
- 2002-05-13 US US10/145,601 patent/US6683086B2/en not_active Expired - Fee Related
-
2004
- 2004-01-23 US US10/763,904 patent/US7041673B2/en not_active Ceased
-
2007
- 2007-12-20 US US12/009,446 patent/USRE41289E1/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2405732A1 (de) * | 1974-02-07 | 1975-08-21 | Bayer Ag | Ekto- und endoparasitenmittel |
| US4237270A (en) * | 1975-02-17 | 1980-12-02 | Spofa, United Pharmaceutical Works | Derivatives of carboxyalkyl imino- and thioxo-barbituric acids |
| US4634707A (en) * | 1983-12-19 | 1987-01-06 | Uniroyal Chemical Company | 5-Pyrimidinecarboxamides and treatment of leukemia and tumors therewith |
| WO1991008191A1 (en) * | 1989-11-14 | 1991-06-13 | Sloan-Kettering Institute For Cancer Research | Novel potent inducers of terminal differentiation and method of use thereof |
| WO1993020064A1 (en) * | 1992-04-06 | 1993-10-14 | Biosite Diagnostics Incorporated | Novel barbiturate derivatives and protein and polypeptide barbiturate derivative conjugates and labels |
| WO1998058925A1 (en) * | 1997-06-21 | 1998-12-30 | Roche Diagnostics Gmbh | Barbituric acid derivatives with antimetastatic and antitumor activity |
Non-Patent Citations (2)
| Title |
|---|
| Chemical Abstract AN: 126:225269 * |
| Mirek J. et al,. Pol. J. Pharmacol., 1978, 30, 6850693 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU5723001A (en) | 2001-11-07 |
| US20020013330A1 (en) | 2002-01-31 |
| WO2001081319A3 (en) | 2002-05-16 |
| US20040167143A1 (en) | 2004-08-26 |
| CA2404898A1 (en) | 2001-11-01 |
| EP1276728A2 (en) | 2003-01-22 |
| US6683086B2 (en) | 2004-01-27 |
| USRE41289E1 (en) | 2010-04-27 |
| US6387914B2 (en) | 2002-05-14 |
| WO2001081319A2 (en) | 2001-11-01 |
| US20030100575A1 (en) | 2003-05-29 |
| JP2003531196A (ja) | 2003-10-21 |
| US7041673B2 (en) | 2006-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| USRE41289E1 (en) | Ultrashort acting hypnotic barbiturates | |
| US3780040A (en) | 2-substituted-3,4-dihydroquinazolines | |
| EP0038541B1 (en) | Novel prodrugs of biologically active agents containing mercapto groups, process for preparing and therapeutically effective composition containing the same | |
| US4225591A (en) | 2,6-Diaminonebularines | |
| CA1320204C (en) | Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters | |
| EP0028833A2 (en) | Imidazole derivatives, their production and use | |
| FR2644789A1 (fr) | Nouveaux steroides 19-nor, 3-ceto comportant une chaine en 17 aminosubstituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant | |
| CA2150162C (fr) | Nouveau n-pyridyl carboxamides et derives, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent | |
| JP2002504916A (ja) | 抗転移及び抗腫瘍活性を有するバルビツール酸誘導体 | |
| AU2001257230A1 (en) | Ultrashort acting hypnotic barbiturates | |
| HU208826B (en) | Process for producing pteridin-4-/3h/-one derivatives and pharmaceutical compositions comprising such derivatives as active ingredient | |
| KR970008108B1 (ko) | 간 장해 억제제 | |
| CA1300619C (en) | 1-(4-hydroxy-3,5-di-tert.-butylbenzoyl)homopiperazine, various derivatives thereof, processes for the preparation of these compounds, medicaments containing them, and their use | |
| US4134991A (en) | Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid | |
| JPS61500019A (ja) | キナゾリン及びイソキノリン誘導体 | |
| US5883092A (en) | Pyrimidine derivatives as endothelin antagonists | |
| FR2631827A1 (fr) | Nouveaux derives d'(hetero)aryl-5 tetrazole, leur procede de preparation et leur application en therapeutique | |
| US3940394A (en) | 2-pyrimidinylthio)alkanoic acids, esters, amides and hydrazides | |
| EP0121806B1 (en) | Pyrazolo(1,5-a)pyridine derivatives and compositions containing them | |
| US3901887A (en) | (2-pyrimidinylthio) alkanoic acids, esters, amides and hydrazides | |
| JPS6229585A (ja) | エーテル化若しくはエステル化しうるジヒドロキシ基により位置2で置換された4―ohキノリンカルボン酸の新規の誘導体、その製造方法、及び医薬としてのその使用 | |
| JP2798628B2 (ja) | 癲癇治療用の5−アミノカルボニル−5H−ジベンゾ[a,d]シクロヘプテン−5,10−イミン | |
| US3896129A (en) | (2-pyrimidinylthio) alkanoic acids, esters, amides and hydrazides | |
| CN100363332C (zh) | 芳香性氨基酸衍生物,其制备方法及其医药用途 | |
| PL144481B1 (en) | Process for preparing derivatives of pyrimidinotrione |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |